HTLV-1, identified 32-years-ago, is present throughout the world with clusters of high
endemicity such as Southwestern Japan, sub-Saharan Africa, South America, the Caribbean …

Introduction: Human T-lymphotropic virus (HTLV) 1 and 2 infections can lead to neurological
diseases, mainly in HIV/HTLV 1 coinfected. Furthermore, HTLV 1 infection in HIV/AIDS …

Human T-lymphotropic virus (HTLV) affects the human immune system in many ways, most
notably by inducing proliferation of infected CD4+ T cells, but several other cell types are …

To investigate serological, epidemiological, and molecular aspects of HTLV-1, HTLV-2, and
HIV-1 infections in Amerindian populations in Brazil, we tested 683 and 321 sera from Tiriyo …

To determine whether coinfection with HTLV-II influences the course of HIV-1 infection, we
evaluated the progression from asymptomatic HIV infection (CDC group II) to persistent …

Studies have shown that HIV-1/HTLV-1 coinfected patients tend to have higher CD4+ counts
than HIV singly infected patients. Two chart reviews were conducted at initial enrolment …

Abstract HTLV–1/HIV-1 co-infection is associated with severe clinical manifestations,
marked immunodeficiency, and opportunistic pathogenic infections, as well as risk behavior …

Background and aims: In Peru, the estimated prevalence of human immunodeficiency virus
(HIV) and human T-lymphotropic virus-1 (HTLV-1) co-infection has been reported to be as …

In the human immunodeficiency virus (HIV)-infected population, especially HIV with
concomitant tuberculosis (TB) or Hodgkin's lymphoma (HL), numerous risk factors have …

Background A cross-sectional study evaluated the cytokines, chemokines and leukotrienes
profiles as possible biomarkers of progression to HTLV-1 associated myelopathy (HAM) …